Industry
Travere Therapeutics Inc [TVTX] Is Currently -2.77 below its 200 Period Moving Avg: What Does This Mean?
Travere Therapeutics Inc [NASDAQ: TVTX] closed the trading session at $6.67. The company report on April 4, 2024 at 4:30 PM that Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International. Posters to be presented highlighting research
